Glucocerebrosidase Gene L444P Mutation is a Risk Factor for Parkinson's Disease in Chinese Population
Glucocerebrosidase Gene L444P Mutation is a Risk Factor for Parkinson's Disease in Chinese Population
复制标题
葡萄糖脑苷脂酶基因L444P突变是中国人群帕金森病的危险因素
DOI:
10.1002/mds.23009
复制
发表时间:
2010-06-15
影响因子:
8.6
通讯作者:
Tang, Bei-Sha
中科院分区:
文献类型:
--
作者:
Sun, Qi-Ying;Guo, Ji-Fen;Tang, Bei-Sha
An association between mutations in the glucocerebrosidase (GBA) gene and Parkinson's disease (PD) has been reported in several populations. We searched for four common GBA mutations (L444P, F213I, R353W, and N370S) in 402 Chinese PD patients and 413 age- and sex-matched controls. In the PD cohort, 11 patients were found carrying a heterozygous GBA mutation and all of them had the L444P mutation. Heterozygous GBA mutations were detected none in controls. The GBA gene L444P mutation was detected at a significantly higher frequency among PD patients (11/402 = 2.74%), when compared with the control group (0/413): P = 0.0007. To evaluate the possible role of the GBA gene L444P mutation in PD in Ashkenazi Jewish and non-Jewish populations, we conducted a meta-analysis on the topic. In the Chinese population, the GBA gene L444P mutation was detected at a significantly higher frequency among PD patients, when compared with the control group: Z = 3.83, P = 0.0001, OR = 8.42, confidence interval = 95%, 2.83-25.06. In the non-Jewish populations, the difference was obviously significant: Z = 5.76, P < 0.00001, OR = 8.82, confidence interval = 95%, 4.21-18.48. The results suggest that the GBA gene L444P mutation appears to be a risk factor for PD in Chinese population. (C) 2010 Movement Disorder Society